José María Sánchez-Pina (Jose Sánchez-Pina, Jose Maria Sánchez-Pina, José Sánchez-Pina, Jose M Sánchez-Pina)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Natural Killer Cells

Radiation Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical medicine

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Maria-Eva Mingot-Castellano, Juan Luis Reguera, Denis Zafra Torres, Rafael Hernani, Oriana Lopez-Godino, Manuel Guerreiro, Blanca Herrero, Lucia López-Corral, Alejandro Luna De Abia, Lesli Gonzalez-Pinedo, Anabelle Chinea, Ana Africa-Martín, Rebeca Bailen, Nuria Martinez-Cibrian, Pascual Balsalobre, Silvia Filaferro, Anna Alonso-Saladrigues, Pere Barba, Pérez-Martínez Antonio, Maria Calbacho, José Antonio Pérez-Simón, José María Sánchez-Pina, null On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. Journal of clinical medicine 13 (17) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Alba Rodríguez-García, Andrés Arroyo, Roberto García-Vicente, Maria Luz Morales, Rubén Gómez-Gordo, Pablo Justo, Clara Cuéllar, José María Sánchez-Pina, Nieves López-Muñoz, Rafael Alonso Fernández, Noemi Puig, Maria-Victoria Mateos-Manteca, Rosa María Ayala, Maria Dulcenombre Gómez-Garré, Joaquin Martinez Lopez, María Linares
Short-chain fatty acid production by gut microbiota predicts treatment response in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Rosa María Ayala, Rafael Alonso Fernández, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Santiago Osorio, José María Sánchez-Pina, Gonzalo Carreño-Tarragona, Noemi Álvarez, María Teresa Gómez-Casares, Antonia Duran, Julian Gorrochategi, Juan Carlos Carlos Hernández-Boluda, Joaquin Martinez-Lopez
Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study. EJHaem 4 (2) (2023)
Ana Jiménez-Ubieto, Juan José Lahuerta, Noemi Puig, María-Teresa Cedena, Joaquin Martinez Lopez, Albert Ortiol, María-Jesús Blanchard, Rafael Ríos, Jesús Martin, Rafael Martínez, Anna Sureda, Miguel-Teodoro T Hernandez Garcia, Javier de la Rubia, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José María Sánchez-Pina, Joan Bargay, Maria-Victoria Mateos-Manteca, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan-José Lahuerta, null null
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change? Blood 138 (19) (2021)
Alejandra Ortiz-Ruiz, Antonio Valeri, Laura Córdoba, Almudena García-Ortiz, Alejandra Ortiz-Ruiz, Laura Sánchez-Vega, Osvaldo Graña-Castro, Lucía Fernández, Gonzalo Carreño-Tarragona, Manuel Pérez, Diego Megías, María Liz Paciello, José María Sánchez-Pina, Antonio Pérez-Martínez, Dean A Lee, Daniel J Powell, Paula Río, Joaquin Martinez Lopez
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma. Blood cancer journal 11 (8) (2021)